KIT and mastocytosis: c-KIT alterations resulting in “gain of function” such as mutation that led to constitutive activation of c-KIT in an SCF-independent manner represent an oncogenic driver in the development of several cancers including gastrointestinal stromal tumor (GIST), melanomas, mastocytosis and acute myeloid leukemia [38].